Abstract
While percutaneous coronary intervention (PCI) with drug-eluting stent (DES) is widely applied to patients with coronary artery disease (CAD), high restenosis rate in hemodialysis (HD) patients treated with early-generation DES was a major clinical concern. Newer generation DES, which has thinner
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
